Hemagen Diagnostics, Inc. (HMGN)

Hemagen Diagnostics Revenue

In the fiscal year ending September 30, 2012, Hemagen Diagnostics had annual revenue of $4.04M, down -21.38%. Hemagen Diagnostics had revenue of $875.91K in the quarter ending September 30, 2012, a decrease of -23.58%. That makes Hemagen Diagnostics the 40,633rd largest company in the world by revenue and 5,429th in the United States.

• Revenue: 4.04M
• Revenue Growth: -21.38%
• P/S Ratio: 0.00
• Revenue / Employee: 269.47K
• Employees: 15
• Market Cap: 3.10K

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Brazil 1.53M 37.9%
• United States 1.27M 31.5%
• Export (Other than Brazil) 1.24M 30.6%

Fiscal year ended Sep 30, 2012

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2012	4.04M	-1.10M	-21.38%
Sep 30, 2011	5.14M	-78.94K	-1.51%
Sep 30, 2010	5.22M	-198.76K	-3.67%
Sep 30, 2009	5.42M	-955.87K	-14.99%
Sep 30, 2008	6.37M	1.89M	42.07%

Data Source: S&P Global Market Intelligence Last updated: Dec 28, 2012

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error